D-0836-2020 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

FDA drug recall D-0836-2020 was initiated by Teva Pharmaceuticals USA on Jan 27, 2020 and is designated Class II. Reason for recall: CGMP deviations: Product bottle may be absent of desiccant. The recall status is terminated (terminated Nov 3, 2020).

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Jan 27, 2020
Termination Date
Nov 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01

Reason for recall

CGMP deviations: Product bottle may be absent of desiccant.

Distribution pattern

USA Nationwide

Code information

Lot #: 1332796 A, Exp 11/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0836-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0836-2020. Report a data issue: hello@regdatalab.com.